Management of Diabetes Mellitus in Patients with Chronic Liver Diseases

Diabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cereb...

Full description

Bibliographic Details
Main Authors: Yingying Zhao, Huichun Xing, Xiaomei Wang, Weini Ou, Hong Zhao, Ben Li, Yue Li, Ying Duan, Liwei Zhuang, Wei Li, Danying Cheng, Min Quan, Yu Zhang, Shibo Ji
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2019/6430486
id doaj-0b5a91e05ffc4525ae63994704889009
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yingying Zhao
Huichun Xing
Xiaomei Wang
Weini Ou
Hong Zhao
Ben Li
Yue Li
Ying Duan
Liwei Zhuang
Wei Li
Danying Cheng
Min Quan
Yu Zhang
Shibo Ji
spellingShingle Yingying Zhao
Huichun Xing
Xiaomei Wang
Weini Ou
Hong Zhao
Ben Li
Yue Li
Ying Duan
Liwei Zhuang
Wei Li
Danying Cheng
Min Quan
Yu Zhang
Shibo Ji
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
Journal of Diabetes Research
author_facet Yingying Zhao
Huichun Xing
Xiaomei Wang
Weini Ou
Hong Zhao
Ben Li
Yue Li
Ying Duan
Liwei Zhuang
Wei Li
Danying Cheng
Min Quan
Yu Zhang
Shibo Ji
author_sort Yingying Zhao
title Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
title_short Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
title_full Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
title_fullStr Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
title_full_unstemmed Management of Diabetes Mellitus in Patients with Chronic Liver Diseases
title_sort management of diabetes mellitus in patients with chronic liver diseases
publisher Hindawi Limited
series Journal of Diabetes Research
issn 2314-6745
2314-6753
publishDate 2019-01-01
description Diabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cerebral vessel damage. DM complications can reduce quality of life and shorten life spans and eventually also impede social and economic development. Therefore, effective measures to curb the occurrence and development of diabetes assist in improving patients’ quality of life, delay the progression of DM in the population, and ease a social burden. The liver is regarded as an important link in the management and control of DM, including the alleviation of glucose metabolism and lipid metabolism and others via glucose storage and endogenous glucose generation from glycogen stored in the liver. Liver cirrhosis is a very common chronic disease, which often lowers the quality of life and decreases life expectancy. According to a growing body of research, diabetes shows a close correlation with hepatitis, liver cirrhosis, and liver cancer. Moreover, coexistence of liver complications would accelerate the deterioration of patients with diabetes. Liver cirrhosis and diabetes influence each other. Thus, in addition to pharmacological treatments and lifestyle interventions, effective control of cirrhosis might assist in a better management of diabetes. When it comes to different etiologies of liver cirrhosis, different therapeutic methods, such as antiviral treatment, may be more effective. Effective control of cirrhosis might be a strategy for better management of diabetes.
url http://dx.doi.org/10.1155/2019/6430486
work_keys_str_mv AT yingyingzhao managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT huichunxing managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT xiaomeiwang managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT weiniou managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT hongzhao managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT benli managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT yueli managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT yingduan managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT liweizhuang managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT weili managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT danyingcheng managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT minquan managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT yuzhang managementofdiabetesmellitusinpatientswithchronicliverdiseases
AT shiboji managementofdiabetesmellitusinpatientswithchronicliverdiseases
_version_ 1725162293080096768
spelling doaj-0b5a91e05ffc4525ae639947048890092020-11-25T01:13:26ZengHindawi LimitedJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/64304866430486Management of Diabetes Mellitus in Patients with Chronic Liver DiseasesYingying Zhao0Huichun Xing1Xiaomei Wang2Weini Ou3Hong Zhao4Ben Li5Yue Li6Ying Duan7Liwei Zhuang8Wei Li9Danying Cheng10Min Quan11Yu Zhang12Shibo Ji13Department of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDepartment of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, ChinaDiabetes mellitus (DM) is a common chronic disease affecting humans globally. During the last few years, the incidence of diabetes has increased and has received more attention. In addition to growing DM populations, DM complications are involving injuries to more organs, such as the heart and cerebral vessel damage. DM complications can reduce quality of life and shorten life spans and eventually also impede social and economic development. Therefore, effective measures to curb the occurrence and development of diabetes assist in improving patients’ quality of life, delay the progression of DM in the population, and ease a social burden. The liver is regarded as an important link in the management and control of DM, including the alleviation of glucose metabolism and lipid metabolism and others via glucose storage and endogenous glucose generation from glycogen stored in the liver. Liver cirrhosis is a very common chronic disease, which often lowers the quality of life and decreases life expectancy. According to a growing body of research, diabetes shows a close correlation with hepatitis, liver cirrhosis, and liver cancer. Moreover, coexistence of liver complications would accelerate the deterioration of patients with diabetes. Liver cirrhosis and diabetes influence each other. Thus, in addition to pharmacological treatments and lifestyle interventions, effective control of cirrhosis might assist in a better management of diabetes. When it comes to different etiologies of liver cirrhosis, different therapeutic methods, such as antiviral treatment, may be more effective. Effective control of cirrhosis might be a strategy for better management of diabetes.http://dx.doi.org/10.1155/2019/6430486